Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Multicenter Translational Study to Validate Molecular Biomarkers (TMB, PD-L1) on Pre-treatment Tumor Tissue as Predictors of Therapy Outcome in Metastatic Melanoma Patients

NCT05750511 is registered in ClinicalTrials.gov with Dermatologic Cooperative Oncology Group as lead sponsor.

NCT NCT05750511
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05750511 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Multicenter Translational Study to Validate Molecular Biomarkers (TMB, PD-L1) on Pre-treatment Tumor Tissue as Predictors of Therapy Outcome in Metastatic Melanoma Patients
Lead sponsor
Dermatologic Cooperative Oncology Group
Phase
Observational
Overall status
Unknown status
Start date
February 1, 2014
Completion date
February 1, 2025
Enrollment
1,000 (estimated)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic melanoma